JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Quanterix Corp

Închisă

SectorSănătate

3.25 1.88

Rezumat

Modificarea prețului

24h

Curent

Minim

3.15

Maxim

3.31

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+70.81% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-141M

155M

Deschiderea anterioară

1.37

Închiderea anterioară

3.25

Sentimentul știrilor

By Acuity

50%

50%

179 / 348 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 apr. 2026, 00:00 UTC

Evenimente importante

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 apr. 2026, 23:33 UTC

Câștiguri

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 apr. 2026, 22:40 UTC

Câștiguri

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 apr. 2026, 22:10 UTC

Achiziții, Fuziuni, Preluări

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 apr. 2026, 21:11 UTC

Câștiguri

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 apr. 2026, 21:01 UTC

Câștiguri

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 apr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22 apr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 apr. 2026, 23:34 UTC

Market Talk
Evenimente importante

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 apr. 2026, 23:16 UTC

Câștiguri

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 apr. 2026, 23:15 UTC

Câștiguri

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 apr. 2026, 22:54 UTC

Câștiguri

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 apr. 2026, 22:54 UTC

Câștiguri

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 apr. 2026, 22:52 UTC

Câștiguri

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 apr. 2026, 22:51 UTC

Câștiguri

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 apr. 2026, 22:31 UTC

Câștiguri

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 apr. 2026, 22:31 UTC

Câștiguri

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 apr. 2026, 22:30 UTC

Câștiguri

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 apr. 2026, 22:30 UTC

Câștiguri

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 apr. 2026, 22:29 UTC

Câștiguri

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 apr. 2026, 22:28 UTC

Câștiguri

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 apr. 2026, 22:28 UTC

Câștiguri

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 apr. 2026, 22:27 UTC

Câștiguri

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 apr. 2026, 22:06 UTC

Market Talk
Câștiguri

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 apr. 2026, 21:55 UTC

Achiziții, Fuziuni, Preluări

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 apr. 2026, 21:47 UTC

Câștiguri

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 apr. 2026, 21:37 UTC

Câștiguri

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 apr. 2026, 21:34 UTC

Câștiguri

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 apr. 2026, 21:29 UTC

Câștiguri

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 apr. 2026, 21:20 UTC

Market Talk
Câștiguri

Tesla Expands Manufacturing to Chips -- Market Talk

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

70.81% sus

Prognoză pe 12 luni

Medie 5.5 USD  70.81%

Maxim 7 USD

Minim 4 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

179 / 348 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat